Clorox Marks 48th Consecutive Dividend Increase Amid Challenges
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 53 minutes ago
0mins
Should l Buy CLX?
Source: Fool
- Dividend Milestone: Clorox has raised its quarterly dividend to $1.24 per share, marking its 48th consecutive annual increase, positioning it to potentially become a Dividend King within the next 15 months, appealing to passive income investors.
- Cash Flow and Earnings Pressure: Despite paying $452 million in dividends in the first three quarters of fiscal 2026, Clorox generated only $161 million in free cash flow, indicating pressure on its profitability that could affect future dividend sustainability.
- Cost Control Measures: Clorox is implementing cost-cutting strategies, such as reducing advertising and administrative expenses, and has completed a $580 million transition to a new enterprise resource planning system aimed at boosting operational efficiency, although its brand competitiveness still needs improvement.
- Deteriorating Financial Condition: Clorox's long-term debt and leverage ratios have reached their highest levels in a decade, reflecting a decline in financial health, and while its gross margin has recovered, it remains below pre-pandemic levels, introducing uncertainty for future growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CLX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CLX
Wall Street analysts forecast CLX stock price to rise
14 Analyst Rating
1 Buy
10 Hold
3 Sell
Hold
Current: 90.010
Low
94.00
Averages
118.69
High
152.00
Current: 90.010
Low
94.00
Averages
118.69
High
152.00
About CLX
The Clorox Company is a multinational manufacturer and marketer of consumer and professional products. Its brands include Brita, Burt's Bees, Clorox, Fresh Step, Glad, Hidden Valley, Kingsford, Liquid-Plumr, Pine-Sol and Purell as well as international brands such as Chux, Clorinda and Poett. Its segments include Health and Wellness, Household, Lifestyle and International. Health and Wellness segment consists of cleaning, disinfecting and professional products marketed and sold in the United States. Products within this segment include home care, cleaning and disinfecting products and laundry additives; professional cleaning and disinfecting products, and others. Household segment consists of bags and wraps, cat litter and grilling products marketed and sold in the United States. Lifestyle segment consists of food, water filtration and natural personal care products marketed and sold in the United States. International segment consists of products sold outside the United States.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Dividend Milestone: Clorox has raised its quarterly dividend to $1.24 per share, marking its 48th consecutive annual increase, positioning it to potentially become a Dividend King within the next 15 months, appealing to passive income investors.
- Cash Flow and Earnings Pressure: Despite paying $452 million in dividends in the first three quarters of fiscal 2026, Clorox generated only $161 million in free cash flow, indicating pressure on its profitability that could affect future dividend sustainability.
- Cost Control Measures: Clorox is implementing cost-cutting strategies, such as reducing advertising and administrative expenses, and has completed a $580 million transition to a new enterprise resource planning system aimed at boosting operational efficiency, although its brand competitiveness still needs improvement.
- Deteriorating Financial Condition: Clorox's long-term debt and leverage ratios have reached their highest levels in a decade, reflecting a decline in financial health, and while its gross margin has recovered, it remains below pre-pandemic levels, introducing uncertainty for future growth.
See More
- Dividend Growth History: Clorox has increased its dividend for 48 consecutive years, with the latest quarterly dividend at $1.24 per share; however, unless it returns to consistent earnings and free cash flow growth, its dividend expenses may become unsustainable.
- Financial Warning Signs: In the nine months ending March 31, 2026, Clorox paid $452 million in dividends but generated only $161 million in free cash flow, indicating that declining profitability could threaten the sustainability of future dividends.
- Cost Control Measures: Clorox is addressing rising manufacturing and logistics costs by reducing advertising investments and selling administrative expenses, and completed a $580 million transition to a new enterprise resource planning system in February to enhance operational efficiency, yet its long-term growth still hinges on brand market resonance.
- Market Competition Pressure: While Clorox's forward P/E ratio of 15.7 may attract value investors, it still faces challenges in brand differentiation and pricing power compared to stable dividend kings like Coca-Cola, needing to demonstrate stronger market performance in the next 15 months.
See More
- Dividend Growth Commitment: Clorox successfully raised its dividend for the 48th consecutive year last July, and despite market challenges, it is on track to achieve the milestone of becoming a Dividend King by 2027, demonstrating the company's long-term commitment to shareholders.
- Market Share Pressure: Although private labels like Costco's Kirkland Signature and Walmart's Great Value are gaining traction, Clorox's CEO noted that private label market share remained flat in the quarter, indicating that consumers still prefer high-quality brands, which provides Clorox with competitive opportunities.
- Sales Forecast Downgrade: Clorox now forecasts a 9% decline in organic sales for fiscal 2026, down from the previous guidance of 5% to 9%, reflecting the operational challenges faced amid intense competition and promotional pressures.
- ERP System Upgrade: Clorox completed a $580 million ERP system upgrade, which, despite being a complex transition affecting the supply chain, is expected to enhance overall operational efficiency and lay the groundwork for future business growth.
See More
- S&P 500 Strong Performance: The S&P 500 index rose by 0.29%, reaching an all-time high, driven by Apple's forecast of stronger-than-expected Q2 revenue, which boosted market sentiment and indicated increased investor confidence in tech stocks.
- Atlassian Stock Surge: Atlassian's stock soared over 29% after reporting Q3 revenue of $1.79 billion, exceeding the market expectation of $1.69 billion, highlighting a robust recovery in the software sector that may attract more investor interest.
- Oil Price Volatility Impacting Markets: WTI crude oil prices fell more than 3%, easing inflation concerns, although trade tensions resurfaced with President Trump's threat to raise tariffs on EU auto imports, potentially negatively affecting market sentiment.
- Economic Data Influencing Stocks: The April ISM manufacturing index remained unchanged at 52.7, below the expected 53.2, indicating signs of economic slowdown, despite the majority of companies reporting Q1 earnings that exceeded expectations, leaving the overall market facing uncertainty.
See More
- Revenue Performance: Clorox reported Q3 revenue of $1.67 billion, exceeding market expectations, indicating the company's resilience in sales despite a challenging overall market environment.
- Market Share Challenges: Despite the revenue beat, Clorox lowered its full-year guidance due to market share issues, reflecting intensified competition and shifts in consumer preferences that may pressure future performance.
- Stock Reaction: Following the guidance downgrade, Clorox's stock fell by 9.7%, heightening investor concerns about the company's growth prospects and potentially leading to short-term capital outflows.
- Need for Strategic Adjustment: In light of declining market share, Clorox must reassess its market strategies to address competitive pressures and restore investor confidence, ensuring long-term sustainable growth.
See More
- Investigation Background: Ademi LLP is investigating Clorox for possible securities fraud due to potentially inaccurate statements regarding its financial statements, business operations, and prospects, which could lead to investor losses.
- Potential Impact: Should the investigation confirm fraudulent activities, Clorox may face legal actions and liability for damages, negatively affecting its stock price and market credibility.
- Investor Participation: Ademi LLP is inviting investors to join the investigation or provide information, indicating the potential widespread impact of this issue and possibly attracting more affected shareholders' attention.
- Legal Expertise: Ademi LLP specializes in securities fraud and shareholder litigation, emphasizing its expertise in such cases, which may enhance investor trust in the investigation's outcomes.
See More











